NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
CompletedPhase 2
Sponsor: Noema Pharma AG
Conditions: Tuberous Sclerosis Complex
Interventions: Basimglurant with crossover to Placebo, Placebo with crossover to Basimglurant
Countries: United States, India, Israel, Italy, Poland, Spain, Turkey (Türkiye), United Kingdom
The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Complex (TSC).
Eligibility overview
Sex: ALL
Age: 5 Years to 30 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria (summary): * Ability and willingness to provide informed assent or written consent or consent from their legal representative. * Fluency in the language of the study staff * Age 5 to 30 years at study entry * A documented history of TSC * Refractory seizure history * Currently receiving one or more anti-epileptic drugs (AEDs) * Stable medications or interventions for epilepsy * Willingness to complete Patient Reported Outcome assessments * For female patients of childbearing potential: 1. Willingness to undergo serum or urinary pregnancy testing at screening and during the trial period. 2. Willingness to use contraception. Exclusion Criteria (summary): * Neurologic disease other than TSC * Recent anoxic episode * Patient weight below 15kg * Clinically significant unstable medical condition(s) * Pregnancy or lactation
Locations (27)
- Los Angeles, California, United States
- Baltimore, Maryland, United States
- Boston, Massachusetts, United States
- Royal Oak, Michigan, United States
- Roseville, Minnesota, United States
- Hawthorne, New York, United States
- Durham, North Carolina, United States
- Cleveland, Ohio, United States
- Houston, Texas, United States
- Hyderabad, Andhra Pradesh, India
- Hyderabad, Andhra Pradesh, India
- Mumbai, Maharashtra, India
- Pune, Maharashtra, India
- New Delhi, National Capital Territory of Delhi, India
- Vellore, Tamil Nadu, India
- Jerusalem, Israel
- Milan, Lombardy, Italy
- Warsaw, Masovian Voivodeship, Poland
- Badalona, Barcelona, Spain
- Esplugues de Llobregat, Barcelona, Spain
- Málaga, Spain
- Seville, Spain
- Fatih, Istanbul, Turkey (Türkiye)
- Kadıköy, Istanbul, Turkey (Türkiye)
- Sultangazi, Istanbul, Turkey (Türkiye)
- Salford, Lancashire, United Kingdom
- Cardiff, South Glamorgan, United Kingdom